Building a Site That Can Take the Next Study

Part of Principal Investigator (PI) Training: The Business of Running a Site.

About 4 minutes. Free, in your language, no account needed.

Why this matters

Module 10 covered making your own oversight durable. This lesson is the other half: what makes a site one that sponsors return to, and that a physician can run without it consuming them.

The two turn out to be the same thing. Sites get chosen for predictability, and predictability is what a system produces.

Know what your team actually does

The most common blind spot in a new investigator is not regulatory. It is not knowing, in any detail, what their coordinator does all day — and you cannot supervise proportionately (§2.3.2) what you cannot picture.

If you learn one more thing after this course, make it that. CRLN's Clinical Research Coordinator course is free, covers the same site from the coordinator's side — start-up, recruitment and screening, consent mechanics, source documentation, safety, monitoring and close-out — and takes about the same time as this one. You are not learning to do their job. You are learning what "adequately supervised" means in practice, and where the work actually gets hard.

The same applies to the roles you interact with: the monitor, the pharmacist, the data manager. Each has a course, and each explains a set of requests that otherwise look arbitrary.

The roles a working site needs

Small sites combine these into fewer people. The functions still have to exist and to be delegated to someone qualified (§2.3.3):

FunctionWhat breaks without it
Principal investigatorNothing else is authorized
Sub-investigator with real capacityNo cover, no succession
CoordinatorEverything operational
Regulatory / essential records ownerSubmissions and the site file drift
Pharmacy or product custodianAccountability findings
Data entry and query resolutionLate data, unanswered queries, delayed payment
Someone who owns qualityNobody notices the pattern

That last row is the one small sites skip, and it is the cheapest. It does not need a full-time person — it needs a named person, an hour a month, and the quarterly self-audit from Module 10.

Capability grows in a specific order

Sites that scale badly take a hard study too early. A workable progression:

  1. One study, run properly, to completion. A clean close-out is your first credential.
  2. A second study in the same therapeutic area, reusing what you learned.
  3. A different phase or a different sponsor, which stresses your processes rather than your knowledge.
  4. Complexity — a device, a decentralized element, an intensive schedule.

Skipping to step four with step-one systems is how a good clinic becomes a site with findings.

What sponsors actually assess

When feasibility questionnaires ask for numbers, they are asking whether you are predictable. Keep them as you go, because reconstructing them later is impossible:

A site that reports honest, unflattering numbers and improves them is more attractive than one that promises well and delivers late. Sponsors have been lied to by optimists before.

The last thing

Everything in these thirteen modules reduces to the question from Module 10 — could I show them? — and one addition for a site rather than a single trial:

If my best coordinator left tomorrow, would this site still run properly next week?

If the honest answer is no, the systems live in a person rather than in the site, and that is the next thing to build.

Key takeaways